GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transition Therapeutics Inc (NAS:TTHI) » Definitions » Dividend Yield %

Transition Therapeutics (Transition Therapeutics) Dividend Yield % : 0.00% (As of May. 06, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Transition Therapeutics Dividend Yield %?

As of today (2024-05-06), the Trailing Annual Dividend Yield of Transition Therapeutics is 0.00%.

The historical rank and industry rank for Transition Therapeutics's Dividend Yield % or its related term are showing as below:

TTHI's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.46
* Ranked among companies with meaningful Dividend Yield % only.

Transition Therapeutics's Dividend Payout Ratio for the three months ended in Mar. 2016 was 0.00.

As of today (2024-05-06), the Forward Dividend Yield % of Transition Therapeutics is 0.00%.

Transition Therapeutics's Dividends per Share for the three months ended in Mar. 2016 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Transition Therapeutics Dividend Yield % Historical Data

The historical data trend for Transition Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transition Therapeutics Dividend Yield % Chart

Transition Therapeutics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Transition Therapeutics Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Transition Therapeutics's Dividend Yield %

For the Biotechnology subindustry, Transition Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transition Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transition Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Transition Therapeutics's Dividend Yield % falls into.



Transition Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Transition Therapeutics  (NAS:TTHI) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Transition Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Transition Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Transition Therapeutics (Transition Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
Transition Therapeutics Inc was incorporated on July 6, 1998 as 'Transition Therapeutics and Diagnostics Inc.' The Corporation filed articles of amendment on October 12, 2000 and on October 19, 2000 to create a class of non-voting shares (the 'Class B Shares') and to amend certain attributes of its Common Shares. On November 2, 2000, the Corporation filed articles of amendment to delete its private company restrictions. On December 14, 2000, the Corporation filed articles of amendment to change its name to 'Transition Therapeutics Inc.' The Company's technologies are focused on the treatment of Alzheimer's disease and diabetes. The Corporation operates in one business segment; that is the research and development of therapeutic agents. Its technologies in development include ELND005 (AZD-103) for the treatment of Alzheimer's disease. On April 30, 2013, the Company announced the results of a five-week proof of concept clinical study of TT401 in type 2 diabetic and obese non-diabetic subjects. In the study, TT401, a once weekly administered peptide, demonstrated improvements in glycemic control and reductions in body weight.
Executives
Jack W Schuler 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Family Foundation Schuler 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045